Obbligazioni TEV
Di seguito è riportato l'elenco delle obbligazioni societarie TEVA PHARMACEUT. SP.ADR. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| TTEVA5034099Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 8,03% | 540 K | 99,13% | 7,13% | 2025-01-31 | 425,259 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 7,00% | 1 M | 99,25% | 6,75% | 2028-03-01 | 255 K USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTEVA P.FI.NL III 16/46 | 6,35% | 0 | 70,91% | 4,10% | 2046-10-01 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 6,09% | 0 | 100,48% | 6,15% | 2036-02-01 | 789,428 M USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5,98% | 10,198 M | 112,19% | 8,13% | 2031-09-15 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 5,94% | 1,136 M | 97,25% | 4,75% | 2027-05-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS219821395TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000 | 5,88% | 0 | 100,12% | 6,00% | 2025-01-31 | 410,607 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5,87% | 5,725 M | 108,51% | 7,88% | 2029-09-15 | 600 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4914602Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 5,84% | 0 | 101,25% | 7,13% | 2025-01-31 | 1,255 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5,84% | 500 K | 102,75% | 6,75% | 2028-03-01 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5,70% | 6,55 M | 97,70% | 5,13% | 2029-05-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFABTEVA P.FI.NL III 16/26 | 5,70% | 0 | 95,44% | 3,15% | 2026-10-01 | 3,378 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4,58% | 0 | 119,53% | 7,88% | 2031-09-15 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS181372460TEVA PH.F.NL.II 18/25 | 4,50% | 0 | 100,00% | 4,50% | 2025-03-01 | 494,346 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 4,42% | 0 | 99,77% | 4,38% | 2030-05-09 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 4,40% | 0 | 113,01% | 7,38% | 2029-09-15 | 800 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 3,95% | 0 | 99,52% | 3,75% | 2027-05-09 | 1,1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 3,85% | 0 | 95,49% | 1,88% | 2027-03-31 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 3,73% | 0 | 92,31% | 1,63% | 2028-10-15 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 2,74% | 430 K | 97,00% | 0,25% | 2026-02-01 | 22,879 M USD | 1.000,00 USD | 1.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 2,14% | 0 | 98,87% | 1,00% | 2025-07-28 | 350 M CHF | 5.000,00 CHF | 5.000,00 CHF | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA3666246IVAX LLC 1.875% 15-DEC-2024 | — | — | — | 1,88% | 2024-12-15 | 333 M USD | 1.000,00 USD | 1.000,00 USD | IVAX LLC |